Inactive Instrument

Natco Pharma Ltd. Share Price NSE India S.E.

Equities

INE987B01018

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR - Intraday chart for Natco Pharma Ltd.

Financials

Sales 2024 39.99B 479M 37.63B Sales 2025 * 47.62B 571M 44.81B Capitalization 179B 2.14B 168B
Net income 2024 13.88B 166M 13.06B Net income 2025 * 17.6B 211M 16.57B EV / Sales 2024 4.26 x
Net cash position 2024 * 15.67B 188M 14.74B Net cash position 2025 * 31.57B 379M 29.71B EV / Sales 2025 * 3.09 x
P/E ratio 2024
12.3 x
P/E ratio 2025 *
10.1 x
Employees -
Yield 2024 *
1%
Yield 2025 *
1.2%
Free-Float 46.76%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 47 02/07/00
Founder 78 18/09/81
Director of Finance/CFO - -
Members of the board TitleAgeSince
Founder 78 18/09/81
Chief Executive Officer 47 02/07/00
Director/Board Member 70 17/04/14
More insiders
Natco Pharma Limited is an India-based vertically integrated pharmaceutical company with focus on research and development. The Company is engaged in in the development, manufacturing and commercialization of complex pharmaceuticals that target specific therapeutic areas. It specializes in catering to niche markets and offering solutions to address complex medical needs. It owns nine manufacturing facilities across India and two research centers in Telangana. The Company’s segment includes Pharmaceuticals and Agro chemicals. Its Pharmaceuticals segment is engaged in manufacturing and selling of bulk drugs, finished dosage formulations and related services. Its Agro Chemicals is engaged in manufacturing and selling of agro chemical. It manufactures active pharmaceutical ingredients products which are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe, and United States of America.
More about the company